MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$14,387K
EPS
-$0.66
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
10,455
16,567
8,613*
13,737
General and administrative
4,629
5,897
3,786*
3,966
Credit loss - related party accounts receivable
-
-
0*
0
Total operating expenses
15,084
22,464
12,398
17,703
Loss from operations
-15,084
-22,464
-12,398*
-17,703
Unrealized gain (loss) on short-term investments
2
-13
-48*
36
Interest and dividend income
695
889
881*
1,351
Total other income, net
697
876
832*
1,387
Net loss
-14,387
-21,588
-11,566
-16,316
Basic EPS
-0.66
-0.99
-0.748
-0.75
Diluted EPS
-0.66
-0.99
-0.748
-0.75
Basic Average Shares
21,846,251
21,815,995
15,469,745
21,713,858
Diluted Average Shares
21,846,251
21,815,995
15,469,745
21,713,858
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
AARD Income Statement Sankey Diagram
Sankey diagram visualizing AARD income statement for the period
Interest and dividend
income
$695K
(-53.29%↓ Y/Y)
Unrealized gain (loss) on
short-term investments
$2K
(128.57%↑ Y/Y)
Net loss
-$14,387K
(-0.14%↓ Y/Y)
Total other income,
net
$697K
(-52.94%↓ Y/Y)
Loss from operations
-$15,084K
(4.82%↑ Y/Y)
Total operating
expenses
$15,084K
(-4.82%↓ Y/Y)
Research and development
$10,455K
(-20.46%↓ Y/Y)
General and
administrative
$4,629K
(71.25%↑ Y/Y)
Buy us a coffee
Aardvark Therapeutics, Inc. (AARD)
Aardvark Therapeutics, Inc. (AARD)